30 Dec 2024 Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes Multiple categories
23 Dec 2024 Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis Member news
05 Dec 2024 BioLizard Launches Bio|Verse® Navigator for Easy Exploration of Complex Biomedical Data Multiple categories
21 Nov 2024 Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation Member news
08 Oct 2024 UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility Member news
23 Aug 2024 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Member news
22 Aug 2024 A potential new oral drug for leishmaniasis has successfully been tested in healthy humans Member news
27 Jun 2024 Biotech company SwiftPharma receives capital injection to achieve ambitious growth Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
